SCHEMBL29566943

SCHEMBL29566943

Cc1cccc(C)c1-c1cc(Oc2ccccc2F)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 2/20 0.47
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ HTR1A P08908 4/20 0.37
▸ HTR7 P34969 4/20 0.37
▸ CCNT1 O60563 2/20 0.35
▸ CDK9 P50750 2/20 0.35
▸ PCK1 P35558 1/20 0.35
▸ CCNB2 O95067 1/20 0.35
▸ CCNE2 O96020 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ CCNB3 Q8WWL7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309515 1.00 BRD4 (0.47) BRD4LMNAHTTTSHRSMN1; SMN2
SCHEMBL29567022 0.93 BRD4 (0.41) BRD4TSHRSMN1; SMN2HTR1AHTR7
SCHEMBL24309574 0.93 BRD4 (0.41) BRD4TSHRSMN1; SMN2HTR1AHTR7
SCHEMBL24309555 0.91 BRD4 (0.40) BRD4TSHRSMN1; SMN2HTR1AHTR7
SCHEMBL26810224 0.89 BRD4 (0.39) BRD4HTTTSHRSMN1; SMN2HTR1A
SCHEMBL24310209 0.88 BRD4 (0.40) BRD4TSHRSMN1; SMN2TDP1HTR1A
SCHEMBL29566559 0.88 BRD4 (0.40) BRD4TSHRSMN1; SMN2TDP1HTR1A
SCHEMBL29566612 0.87 TSHR (0.43) BRD4LMNAHTTTSHRSMN1; SMN2
SCHEMBL24310345 0.87 TSHR (0.43) BRD4LMNAHTTTSHRSMN1; SMN2
SCHEMBL26812102 0.87 BRD4 (0.38) BRD4LMNATSHRSMN1; SMN2CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback